Australian Pharmaceutical

SYDNEY, AUSTRALIA: Wesfarmers Limited has proposed to acquire 100 per cent of the shares in Australian Pharmaceutical Industries (API) for cash consideration of $1.55 per share (Revised Proposal). In July this year, Wesfarmers Ltd had submitted a non-binding, indicative offer to acquire…